Infection and Encephalitis

  • Kim M. Cecil
  • Diana M. Lindquist


Magnetic resonance spectroscopy (MRS) serves as a powerful tool in narrowing the differential diagnosis in pediatric brain disorders. Unfortunately, the literature provides only a limited number of case reports and larger patient series employing this technique in the diagnosis and monitoring of infectious and inflammatory conditions. For these conditions producing encephalitis, MRS often demonstrates a more benign spectral appearance, with minor changes in metabolite levels, which contrasts to the typically more dramatic and often aggressive spectral features recognized in neoplasms and metabolic disorders. One key exception is frank abscess, as this process depletes the metabolites found in normal brain parenchyma and replaces them with distinct amino acids. This chapter first describes some practical and technical concerns associated with conducting neurological MRS studies in the pediatric patients to confirm the diagnosis of an infectious and/or inflammatory process. A brief description of infectious disorders and inflammatory conditions with illustrative imaging and spectroscopy examples from our center and the literature will provide important information in diagnosing these conditions.


Human Immunodeficiency Virus Epstein Barr Virus Magnetic Resonance Spectroscopy Acquire Immune Deficiency Syndrome Brain Abscess 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by grants from the National Institutes of Health, NIEHS R01 ES015559, NCI R01 CA112182, and NIMH P50 MH077138. The authors have no competing financial or non-financial interests to declare.


  1. 1.
    Christopher MM, Eckfeldt JH, Eaton JW. Propylene glycol ingestion causes D-lactic acidosis. Lab Invest. 1990;62(1):114–8.PubMedGoogle Scholar
  2. 2.
    Lange T, Dydak U, Roberts TP, Rowley HA, Bjeljac M, Boesiger P. Pitfalls in lactate measurements at 3 T. AJNR Am J Neuroradiol. 2006;27(4):895–901.PubMedGoogle Scholar
  3. 3.
    Klomp DW, van der Graaf M, Willemsen MA, van der Meulen YM, Kentgens AP, Heerschap A. Transmit/receive headcoil for optimal 1 H MR spectroscopy of the brain in paediatric patients at 3 T. MAGMA. 2004;17(1):1–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Liu HS, Chung HW, Juan CJ, et al. Anomalous J-modulation effects on amino acids in clinical 3 T MR spectroscopy. AJNR Am J Neuroradiol. 2008;29(9):1644–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Pal D, Bhattacharyya A, Husain M, Prasad KN, Pandey CM, Gupta RK. In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol. 2010;31(2):360–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Lai PH, Hsu SS, Ding SW, et al. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol. 2007;68 Suppl 1:S25–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Luthra G, Parihar A, Nath K, et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol. 2007;28(7):1332–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Vajro P, Sokal EM, Maddaluno S, et al. Brain abscess due to Klebsiella pneumoniae in a liver-transplanted child. Transpl Infect Dis. 2009;11(4):341–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Jain KK, Mittal SK, Kumar S, Gupta RK. Imaging features of central nervous system fungal infections. Neurol India. 2007;55(3):241–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Kingsley PB, Shah TC, Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed. 2006;19(4):435–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferraz-Filho JR, Santana-Netto PV, Rocha-Filho JA, Sgnolf A, Mauad F, Sanches RA. Application of magnetic resonance spectroscopy in the differentiation of high-grade brain neoplasm and inflammatory brain lesions. Arq Neuropsiquiatr. 2009;67(2A):250–3.PubMedCrossRefGoogle Scholar
  12. 12.
    Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology. 1995;197(2):525–31.PubMedGoogle Scholar
  13. 13.
    Keller MA, Venkatraman TN, Thomas A, et al. Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests. Neurology. 2004;62(10):1810–7.PubMedCrossRefGoogle Scholar
  14. 14.
    van der Voorn JP, Pouwels PJ, Vermeulen RJ, Barkhof F, van der Knaap MS. Quantitative MR imaging and spectroscopy in congenital cytomegalovirus infection and periventricular leukomalacia suggests a comparable neuropathological substrate of the cerebral white matter lesions. Neuropediatrics. 2009;40(4):168–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis. 2003;36(6):731–42.PubMedCrossRefGoogle Scholar
  16. 16.
    Whitley RJ. Viral encephalitis. N Engl J Med. 1990;323(4):242–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Porto L, Hattingen E, Pilatus U, et al. Proton magnetic resonance spectroscopy in childhood brainstem lesions. Childs Nerv Syst. 2007;23(3):305–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Menon DK, Sargentoni J, Peden CJ, et al. Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. J Comput Assist Tomogr. 1990;14(3):449–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Takanashi J, Sugita K, Ishii M, Aoyagi M, Niimi H. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. J Neurol Sci. 1997;149(1):99–102.PubMedCrossRefGoogle Scholar
  20. 20.
    Cecil KM, Jones BV, Williams S, Hedlund GL. CT, MRI and MRS of Epstein-Barr virus infection: case report. Neuroradiology. 2000;42(8):619–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Mader I, Wolff M, Nagele T, Niemann G, Grodd W, Kuker W. MRI and proton MR spectroscopy in acute disseminated encephalomyelitis. Childs Nerv Syst. 2005;21(7):566–72.PubMedCrossRefGoogle Scholar
  22. 22.
    Seo HE, Hwang SK, Choe BH, Cho MH, Park SP, Kwon S. Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in children. J Korean Med Sci. 2010;25(3):449–53.PubMedCrossRefGoogle Scholar
  23. 23.
    Marco EJ, Anderson JE, Neilson DE, Strober JB. Acute necrotizing encephalopathy in 3 brothers. Pediatrics. 2010;125(3):e693–698.PubMedCrossRefGoogle Scholar
  24. 24.
    Mastroyianni SD, Gionnis D, Voudris K, Skardoutsou A, Mizuguchi M. Acute necrotizing encephalopathy of childhood in non-Asian patients: report of three cases and literature review. J Child Neurol. 2006;21(10):872–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Yu Q, Yang J, Wang P. Malignant tumors and chronic infections in the masticator space: preliminary assessment with in vivo single-voxel 1 H-MR spectroscopy. AJNR Am J Neuroradiol. 2008;29(4):716–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Departments of Radiology, Pediatrics, Neuroscience and Environmental Health, Cincinnati Children’s Hospital Medical CenterUniversity of Cincinnati College of MedicineCincinnatiUSA
  2. 2.Departments of Radiology, Cincinnati Children’s Hospital Medical CenterUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations